The IDDST-2023 Scientific Committee is inviting the submission of scientific abstracts for
proffered paper and poster sessions.
Authors are asked to submit abstracts under one of the following categories, but not limited:
ADME Tox |
HTS |
Biochemistry |
Imaging |
Biopharmaceuticals |
Immunology |
Cancer Biology |
Lead Discovery & Profiling |
Cardiology |
Medicinal Chemistry |
Cell Biology |
Microbiology |
Cellular Hit Identification |
Molecular Pharmacology |
Chemistry |
Oncology |
Clinical Development |
Pharmacokinetics |
Clinical Pharmacology |
R&D |
Clinical R&D |
Structural Biochemistry |
DMPK |
Target Discovery |
Drug Discovery & Development |
Toxicology |
Drug Safety & Metabolism |
Translational Sciences |
Enabling Technologies |
Virology |
Abstracts must be in English and contain a maximum of 2800 characters with space in Microsoft Word. A data
table may be included where required, but will count as 600 characters against the 2800 characters total. A
maximum of 1 image file may also be included, but each image will count as 600 characters against the 2800
characters total. All abstracts accepted by the Scientific Committee will be published in the conference
proceeding. The Scientific Committee will review all submitted abstracts, and will determine if an abstract is
to be presented orally, by poster, or by publication only.
Abstracts failing to meet minimum standards or are not relevant to this conference will be declined. Authors
may submit multiple abstracts, but usually an individual will not be offered more than one oral presentation.
© 2003-2023 All rights reserved by BITeomics |